Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Martin Tami Tillotson. Insider active across 1 company, notably Supernus Pharmaceuticals, INC.. In total, 10 disclosures have been published. Split: 0 buy · 1 sell. Total volume traded: €150k. History available since 4 August 2022. The latest transaction was filed on 23 February 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Martin Tami Tillotson is a declarant connected to Supernus Pharmaceuticals, INC. as Sr. V.P., Regulatory Affairs. He has 10 filings in total, and among the 10 sampled filings, transactions span from 2022-08-05 to 2024-02-27, with EUR 0 in buys and EUR 150211 in sells. The modal transaction nature is option exercise.